New research gives hope in the fight against pancreatic cancer
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO Pancreatic ductal adenocarcinoma (PDAC), the most common…
Browsing: Immunotherapy
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people…
Pancreatic cancer specialist explains challenges of the disease and treatment advances
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…
ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit
Immunotherapy is a revolutionary cancer treatment, but it was unknown if cancer patients with HIV…
ASCO 2019: T-VEC shows improved survival over cytokine therapy in patients with melanoma
Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma…
ASCO 2019: Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response…
ASCO 2019: Pembrolizumab increases historic survival rate for certain people with advanced non-small cell lung cancer
Five-year data from the phase Ib KEYNOTE-001 clinical trial show that pembrolizumab was safe and…
Ipilimumab-heavy immunotherapy combination in metastatic bladder cancer
An immunotherapy combination with a higher dose of ipilimumab produced a 38 percent overall response…
Vaccine design can dramatically improve cancer immunotherapies
When it comes to the effectiveness of nanotherapeutic vaccines, shape matters. A Northwestern University team…
How we are developing immunotherapies relevant to Africa
Neelakshi Mungra, University of Cape Town; Krupa Naran, University of Cape Town, and Trishana Nundalall…